Characterization of a multidisciplinary team's role in hospital discharge for patients receiving hypomethylating agents with venetoclax as induction therapy for acute myeloid leukemia.
Vera PervitskyJulie GuglielmoBenjamin MoskoffRoxie KneenCarol LeijaDeborah SawickyMargaret Li KrackelerBrian A JonasRyan J BeechinorPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2023)
The utilization of an interdisciplinary AML team to target early hospital discharge proved to be safe and effective and led to a reduction in costs for the health system. Future research may identify select patients who may be suitable for earlier discharge or outpatient induction.